Pregled bibliografske jedinice broj: 1124959
Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies
Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies // Journal of Virological Methods, 293 (2021), 114173, 15 doi:10.1016/j.jviromet.2021.114173 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1124959 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Diagnostic accuracy of three SARS-CoV2 antibody
detection assays, neutralizing effect and
longevity of serum antibodies
Autori
Bubonja-Šonje, Marina ; Batičić, Lara ; Abram, Maja ; Cekinović Grbeša, Đurđica
Izvornik
Journal of Virological Methods (0166-0934) 293
(2021);
114173, 15
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Antibody testingCOVID-19SARS-CoV-2 neutralizing activitySerological testing
Sažetak
Evidence is currently insufficient to know whether SARS-CoV-2 antibodies (Abs) protect from future infection and how long immunity will last. The kinetics of the immune response to SARS-CoV-2 infection and role of serology in estimating individual protective immunity is yet to be established. We evaluated diagnostic performances of three serological assays - Abbott Architect CMIA IgG, bioMerieux VIDAS ELFA IgG/IgM, and Diesse Chorus ELISA IgG/IgM, and analyzed longevity and potential neutralizing effect of SARS-CoV-2 Abs in COVID-19 patients. Clinical sensitivities of assessed IgG tests two to three weeks post symptom onset (PSO) were very high: 96.77 % for Architect, 96.77 % for Chorus, and 100.00 % for VIDAS. Sensitivities of two assessed IgM assays were moderate: 74.07 % for Chorus, and 76.92 % for VIDAS. Specificities were excellent for all assessed IgG assays: 99.01 % for Architect and 100 % for Chorus and VIDAS. Chorus and VIDAS IgM assays also achieved excellent specificity of 99.01 % and 100 %, respectively. In most cases IgG Abs were still present eight months PSO. Neutralizing antibodies were detected in majority of serum samples from convalescent patients. Serum samples from severe COVID-19 patients had higher antibody titers and higher neutralizing activity. We observed a strong positive correlation among SARS-CoV-2 IgG antibody titer and neutralizing activity. The strongest positive correlation to neutralizing activity was found for VIDAS IgG assay.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
--uniri-biomed-18-215 - Proširenost i klinički značaj HBs antigenih mutanti virusa hepatitisa B (Bubonja Šonje, Marina) ( CroRIS)
--uniri-biomed-18-277 - Bakterijska patogeneza - od istraživanja do kliničke primjene (Abram, Maja) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Profili:
Đurđica Cekinović Grbeša (autor)
Lara Batičić (autor)
Maja Abram (autor)
Marina Bubonja Šonje (autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE